Quantbot Technologies LP Sells 50,506 Shares of Nu Skin Enterprises, Inc. (NYSE:NUS)

Quantbot Technologies LP trimmed its position in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) by 50.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 48,992 shares of the company’s stock after selling 50,506 shares during the period. Quantbot Technologies LP owned about 0.10% of Nu Skin Enterprises worth $338,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Geode Capital Management LLC increased its position in shares of Nu Skin Enterprises by 1.1% during the third quarter. Geode Capital Management LLC now owns 1,130,487 shares of the company’s stock worth $8,333,000 after acquiring an additional 11,838 shares during the period. Jane Street Group LLC increased its position in shares of Nu Skin Enterprises by 358.4% during the third quarter. Jane Street Group LLC now owns 924,993 shares of the company’s stock worth $6,817,000 after purchasing an additional 723,220 shares in the last quarter. Bank of New York Mellon Corp boosted its holdings in Nu Skin Enterprises by 18.5% in the fourth quarter. Bank of New York Mellon Corp now owns 613,330 shares of the company’s stock worth $4,226,000 after acquiring an additional 95,938 shares in the last quarter. Hotchkis & Wiley Capital Management LLC boosted its stake in Nu Skin Enterprises by 27.7% in the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 603,555 shares of the company’s stock worth $4,448,000 after purchasing an additional 130,980 shares in the last quarter. Finally, Prescott Group Capital Management L.L.C. lifted its stake in shares of Nu Skin Enterprises by 3.2% during the fourth quarter. Prescott Group Capital Management L.L.C. now owns 574,636 shares of the company’s stock worth $3,959,000 after buying an additional 17,623 shares during the period. 82.84% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

NUS has been the topic of a number of recent research reports. DA Davidson dropped their target price on Nu Skin Enterprises from $11.00 to $7.00 and set a “neutral” rating on the stock in a research report on Friday, December 20th. StockNews.com upgraded Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Tuesday, February 25th.

Nu Skin Enterprises Price Performance

Shares of NYSE NUS opened at $7.20 on Friday. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.17 and a current ratio of 1.82. The firm has a market cap of $357.86 million, a PE ratio of -2.44 and a beta of 1.06. Nu Skin Enterprises, Inc. has a one year low of $5.95 and a one year high of $14.00. The firm has a fifty day moving average of $7.37 and a 200 day moving average of $7.09.

Nu Skin Enterprises (NYSE:NUS) last issued its quarterly earnings results on Thursday, February 13th. The company reported $0.38 earnings per share for the quarter, beating analysts’ consensus estimates of $0.24 by $0.14. Nu Skin Enterprises had a negative net margin of 8.46% and a positive return on equity of 5.86%. The firm had revenue of $445.55 million for the quarter, compared to analyst estimates of $441.10 million. As a group, research analysts predict that Nu Skin Enterprises, Inc. will post 1.05 EPS for the current fiscal year.

Nu Skin Enterprises Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 5th. Investors of record on Monday, February 24th were paid a $0.06 dividend. This represents a $0.24 annualized dividend and a yield of 3.33%. The ex-dividend date of this dividend was Monday, February 24th. Nu Skin Enterprises’s dividend payout ratio is currently -8.14%.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.